Archive: 18/08/2016

New study shows LSD's effects on language

The consumption of LSD, short for lysergic acid diethylamide, can produce altered states of consciousness. This can lead to a loss of boundaries between the self and the environment, as might occur in certain psychiatric ...

Aug 18, 2016

Personalised wearable tech can help adults diagnosed with autism manage anxiety

Personalised wearable digital technology can help adults diagnosed with autism understand and manage their anxiety.

Aug 18, 2016

0

5

New study finds homebound, elderly patients missing out on in-home care

The saying goes that "what is old is new again." Many elderly Americans are hoping that proves true.

Aug 18, 2016

0

3

Childhood adversity looms large for older homeless adults

A new UC San Francisco report on an understudied population – older homeless adults – reveals that adverse childhood experiences have long-lasting effects. The researchers found that childhood adversities, such as abuse, ...

Aug 18, 2016

Concussion rates rising significantly in adolescents

The number of Americans diagnosed with concussions is growing, most significantly in adolescents, according to researchers at UC San Francisco. They recommend that adolescents be prioritized for ongoing work in concussion ...

Aug 18, 2016

Doctors paid by drug companies more likely to use those companies' meds

Ophthalmologists who receive money from pharmaceutical companies are more likely to prescribe medications promoted by those companies than similar drugs that are less costly, a new study shows.

Aug 18, 2016

0

1

Expert discusses MDMA research

Neuroscientist Robert Malenka, MD, PhD, the Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences, has conducted trailblazing inquiries into the nature of the brain's reward circuitry. This archipelago of ...

Aug 18, 2016

Novel therapy holds promise of remission in relapsed patients with diffuse large B-cell lymphoma

A phase 2 clinical trial of a novel therapy for patients who have experienced a relapse of diffuse large B-cell lymphoma (DLBCL) resulted in extended remission, averaging 14.5 months, and longer than three years in exceptional ...

Aug 18, 2016